C&EN White Paper
Solutions for the LC-MS/MS determination of nitrosamine impurities in pharmaceutical API’s and addressing issues associated with DMF and NDMA co-elution
Brought to you by MAC-MOD Analytical

The detection and quantification of nitrosamine impurities in pharmaceutical materials has become a topic of global concern in recent years. Nitrosamine analysis is challenging and requires the application of highly selective and sensitive analytical techniques, capable of quantification in the low ppb range. This white paper discusses how LC-MS/MS methods can be developed and applied to the determination of a range of nitrosamine impurities, highlighted by regulatory authorities, in pharmaceutical APIs.

Additionally, the impact of isobaric interference from N,N-dimethylformamide (DMF), which may co-elute with and result in over-quantification of NDMA, is assessed. Varying the LC stationary phase chemistry to improve chromatographic retention and resolution of NDMA and DMF, along with considered selection of appropriate MRM transitions, was found to provide a solution to improve NDMA quantification accuracy.

Participants Will Learn How:
  • Why nitrosamine analysis is important
  • How to detect and quantify nitrosamines impurities by LC-MS/MS.
  • Strategies to avoid interference from other low molecular weight trace impurities, such as DMF.

Brought to you by:
MAC-MOD Analytical
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy .

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy